Sclerosis News and Research

RSS

Pilot trial tests nasal monoclonal antibody treatment for COVID-19

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the drug Foralumab, an anti-CD3 monoclonal antibody.

8 Mar 2023

What is the impact of oral cannabidiol on simulated driving?

Researchers assessed the impact of cannabidiol on the driving performance of humans.

6 Mar 2023

Study reveals a chemical compound for the treatment of autoimmune diseases

Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune diseases like multiple sclerosis and rheumatoid arthritis.

5 Mar 2023

Associations between structural brain alterations and post-COVID fatigue

In a recent study published in eClinicalMedicine, researchers examined the structural brain changes in patients with post-COVID fatigue.

3 Mar 2023

UK HealthCare neurologist helps to compile an essential list of MS medications

Together with Multiple Sclerosis (MS) experts, biostatisticians and clinicians from across the globe, a UK HealthCare neurologist has helped compile an essential list of MS medications for patients in resource-poor settings.

3 Mar 2023

Government funding to accelerate research in AI healthcare technologies

Tens of thousands of patients across the country could benefit from quicker, earlier diagnoses and more effective treatments for a range of conditions - as the government invests nearly £16 million into pioneering artificial intelligence research (AI).

3 Mar 2023

Research investigates roles of neurotrophic factors on cognition in Alzheimer's patients carrying APOE ε4

Researchers investigate the role of neurotrophic factors on the cognitive performance of Alzheimer’s disease patients carrying the apolipoprotein E 4 gene.

1 Mar 2023

Study reveals synergistic impact of estrogen and intestinal dysbiosis on pulmonary fibrosis

In a recent study published in Cells, researchers evaluated idiopathic pulmonary fibrosis (IPF) pathophysiological differences by sex and intestinal microbiome.

1 Mar 2023

Using artificial intelligence methods to predict the prevalence of ALS

Amyotrophic lateral sclerosis (ALS)—a severe disease of the motor nervous system—is hereditary, but a large part of this heritability has previously been unexplained.

28 Feb 2023

Common RNA modification plays a key role in TDP-43-related neurodegeneration in ALS

Nearly 100% of cases of amyotrophic lateral sclerosis - the progressive, fatal neurodegenerative disease known as ALS or Lou Gherig's disease - involve the buildup of a protein called TDP-43.

27 Feb 2023

Research identifies proteins that may contribute to onset of common metabolic diseases

New research has identified hundreds of proteins that might contribute to the onset of common, chronic metabolic diseases such as type 2 diabetes, and consequently pathways to potential treatments.

24 Feb 2023

Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

The researchers investigated the impact of coronavirus disease 2019 (COVID-19) on the progression of clinical disability in multiple sclerosis patients.

24 Feb 2023

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

Researchers presented eight hallmarks of neurodegenerative diseases (NDDs), their in vivo biomarkers, and interactions to help categorize NDDs and specify patients within a specific NDD.

21 Feb 2023

California requires hospitals to turn to a patient’s next of kin, closing a longtime loophole

About four years ago, Dr. Gene Dorio sat on the ethics committee of a Southern California hospital whose administrators insisted they could decide whether to disconnect a ventilator from an unconscious patient — even though the man's wife and adult children wanted to continue life support.

17 Feb 2023

Neuroscientists discover new way to disrupt chronic inflammation responsible for multiple sclerosis

UVA Health neuroscientists have discovered a potential way to disrupt the chronic inflammation responsible for multiple sclerosis.

16 Feb 2023

Major funding boost for research on neurodegenerative diseases

Brain Canada and the Canadian Institutes of Health Research congratulate Dr. Meaghan O'Reilly from Sunnybrook Research Institute and the University of Toronto as well as Dr. Liang Li based out of University of Alberta whose projects have been recommended for funding as part the 2022 European Union Joint Programme on Neurodegenerative Disease Research (JPND)'s initiative to find causes, develop cures and identify better ways to care for people with Alzheimer's, Parkinson's, Huntington's and other neurodegenerative diseases more rapidly.

16 Feb 2023

Study highlights the interconnectedness of autoimmunity and cancer

In a recent study published in the journal Immunity, researchers reviewed the T cell response in cancer and autoimmunity to propose strategies for more effective immunotherapies.

15 Feb 2023

New method provides important insights into the development of epilepsy

In epilepsy research, it has long been assumed that a leaky blood-brain barrier is a cause of inflammation in the brain.

13 Feb 2023

Research reveals differences in the gut microbiomes of people with ME/CFS

The study was led by scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health, as part of the Center for Solutions for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, an inter-disciplinary, inter-institutional research group dedicated to understanding the biology of the disease in order to develop effective means to diagnose, treat and prevent it.

8 Feb 2023

USC researchers identify two promising avenues for developing new ALS treatments

Each year in the U.S., 5,000 patients receive a diagnosis of ALS, an incurable neurodegenerative disease that will likely kill them within two to five years.

7 Feb 2023

Sclerosis News and Research

Pilot trial tests nasal monoclonal antibody treatment for COVID-19

What is the impact of oral cannabidiol on simulated driving?

Study reveals a chemical compound for the treatment of autoimmune diseases

Associations between structural brain alterations and post-COVID fatigue

UK HealthCare neurologist helps to compile an essential list of MS medications

Government funding to accelerate research in AI healthcare technologies

Research investigates roles of neurotrophic factors on cognition in Alzheimer's patients carrying APOE ε4

Study reveals synergistic impact of estrogen and intestinal dysbiosis on pulmonary fibrosis

Using artificial intelligence methods to predict the prevalence of ALS

Common RNA modification plays a key role in TDP-43-related neurodegeneration in ALS

Research identifies proteins that may contribute to onset of common metabolic diseases

Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

California requires hospitals to turn to a patient’s next of kin, closing a longtime loophole

Neuroscientists discover new way to disrupt chronic inflammation responsible for multiple sclerosis

Major funding boost for research on neurodegenerative diseases

Study highlights the interconnectedness of autoimmunity and cancer

New method provides important insights into the development of epilepsy

Research reveals differences in the gut microbiomes of people with ME/CFS

USC researchers identify two promising avenues for developing new ALS treatments

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News